‘Member States shall transmit to the Agency the names of national experts with proven experience in the evaluation of medicinal products for human use who, taking into account Article 63(2), would be available to serve on working parties or scientific advisory groups of any of the Committees referred to in Article 56(1), together with an indication of their qualifications and specific areas of expertise’.

The Commission has monitored and, where relevant, participated in the activities of the relevant international organisations, such as the Council of Europe (Working group on biomedical research, which is drafting a protocol on biomedical research; Working group on biotechnology; Working group on human genetics, which is drafting a protocol on human genetics; and Steering Committee on Bioethics), UNESCO and the UN.

In particular, an evaluation of the clinical validity/utility of genetic tests and the establishment of a referral system at EU level for genetic testing of rare and complex diseases will be addressed in 2005- 2006 to take whatever action appropriate or required, as arising from the coordination The Commission will launch an initiative on the protection of workers' personal data in the employment context, taking account of the European Group on Ethics in Science and New Technologies Opinion No 18 “Ethical Aspects of Genetic Testing in the Workplace”.

In particular, an evaluation of the clinical validity/utility of genetic tests and the establishment of a referral system at EU level for genetic testing of rare and complex diseases will be addressed in 2005- 2006 to take whatever action appropriate or required, as arising from the coordination The Commission will launch an initiative on the protection of workers' personal data in the employment context, taking account of the European Group on Ethics in Science and New Technologies Opinion No 18 “Ethical Aspects of Genetic Testing in the Workplace”.

Full use must be made of the new Council Framework Decision on Confiscation of Crime-Related Proceeds, Instrumentalities and Property.[xl] The work of the Financial Action Task Force, in particular of the Working Group on Typologies (WGTYP), which focuses, inter alia, on Money Laundering Methods Associated with Human Being Trafficking , must be followed and evaluated in order to develop further political and operational options to combat human trafficking.

(8) Whereas, without prejudice to the other requirements in Community legislation relating to the labelling of foodstuffs, additional specific requirements on labelling should be laid down; whereas these requirements must be subject to precise provisions in order to ensure that the necessary information is available to the consumer; whereas defined population groups associated with well established practices regarding food should be informed when the presence in a novel food of material which is not present in the existing equivalen ...[+++]t foodstuff gives rise to ethical concerns as regards those groups; whereas foods and food ingredients which contain genetically modified organisms and which are placed on the market must be safe for human health; whereas this assurance is provided for through compliance with the authorization procedure contained in Directive 90/220/EEC and/or by the single assessment procedure laid down in this Regulation; whereas insofar as an organism is defined by Community law, with respect to labelling, information to the consumer on the presence of an organism which has been genetically modified constitutes an additional requirement applicable to the foods and food ingredients referred to in this Regulation;